FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and concerns use of cathepsin H to identify compounds modulating neuropathic pain. The group of inventions also concerns using a cell providing heterologous expression of cathepsin H or its functional fragment, to identify the compounds modulating neuropathic pain; use of a cathepsin H knock-out cell to identify or analyse the compounds modulating neuropathic pain; a method for identifying or analysing the compounds modulating and/or preventing neuropathic pain.
EFFECT: group of inventions provides identifying the compounds modulating neuropathic pain.
16 cl, 1 ex, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF "¦L¦" | 2004 |
|
RU2345785C2 |
| TRANSGENIC ANIMAL THAT DIFFERS FROM HUMAN, AND ITS APPLICATION | 2010 |
|
RU2579701C2 |
| CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND TNFα ANTAGONIST DOMAIN | 2015 |
|
RU2678810C2 |
| REGULATION OF METABOLISM USING MIR-378 | 2011 |
|
RU2585491C2 |
| S1P APPLICATION | 2004 |
|
RU2362565C2 |
| ANALGETIC AGENT ON THE BASIS OF PLASMID DNA CODING HNP-1, OR HNP-2, OR HNP-3 (VERSIONS) | 2014 |
|
RU2597789C2 |
| NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS | 2006 |
|
RU2427387C2 |
| NON-HUMAN ANIMALS WITH A GYRATE DEFICIENCY | 2014 |
|
RU2721855C2 |
| RAD3 POLYPEPTIDE ATR HOMOLOGUES, POLYNUCLEUTIDES AND RELATED METHODS AND MATERIALS | 1996 |
|
RU2252256C2 |
| METHOD OF SCREENING GAMMA-SECRETASE INHIBITORS | 2004 |
|
RU2373284C2 |
